| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5948708 | Atherosclerosis | 2012 | 6 Pages |
Abstract
⺠Metabolic syndrome is a risk factor in CAD patients following stent implantation. ⺠DES implantation decreases angiographic events in metabolic syndrome patients. ⺠Adequate treatment of MetS is required to improve the outcome in CAD patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Di Xu, Yan Guo, Hui Wang, Bing Gu, Genyan Liu, Chuanwei Zhou, Xin Wu, Junhong Wang, Kejiang Cao,